Insider Transactions in Q1 2021 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.3%
|
$93,296
$56.21 P/Share
|
|
Mar 29
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,822
-1.71%
|
$152,388
$54.62 P/Share
|
|
Mar 22
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
2,538
+35.72%
|
-
|
|
Mar 22
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-4.69%
|
-
|
|
Mar 15
2021
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Indirect |
50,000
-1.41%
|
$3,100,000
$62.4 P/Share
|
|
Mar 09
2021
|
Ryan J. Watts President and CEO |
SELL
Bona fide gift
|
Indirect |
40,000
-1.73%
|
-
|
|
Mar 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.93%
|
$610,000
$61.24 P/Share
|
|
Mar 03
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.3%
|
$101,626
$61.89 P/Share
|
|
Mar 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,334
-0.11%
|
$1,228,378
$67.62 P/Share
|
|
Mar 01
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
100,000
-0.53%
|
$6,700,000
$67.65 P/Share
|
|
Mar 01
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
7,092
-0.6%
|
$475,164
$67.93 P/Share
|
|
Feb 16
2021
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Indirect |
50,000
-1.34%
|
$3,250,000
$65.58 P/Share
|
|
Feb 12
2021
|
Douglas K Bratton > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,216,798
-18.17%
|
$144,091,870
$65.0 P/Share
|
|
Feb 11
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
9,473
-0.2%
|
$663,110
$70.82 P/Share
|
|
Feb 11
2021
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
3,035
-1.51%
|
$212,450
$70.8 P/Share
|
|
Feb 11
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
3,047
-0.28%
|
$213,290
$70.79 P/Share
|
|
Feb 11
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
3,156
-0.9%
|
$220,920
$70.83 P/Share
|
|
Feb 09
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,470
-0.29%
|
$110,250
$75.17 P/Share
|
|
Feb 09
2021
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,448
-5.13%
|
$107,152
$74.88 P/Share
|
|
Feb 09
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
1,468
-0.14%
|
$110,100
$75.17 P/Share
|
|
Feb 09
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
5,112
-0.07%
|
$378,288
$74.12 P/Share
|
|
Feb 08
2021
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
14,316
+0.31%
|
-
|
|
Feb 07
2021
|
Carole Ho Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,250
+2.45%
|
-
|
|
Feb 07
2021
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+22.76%
|
-
|
|
Feb 07
2021
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,250
+0.78%
|
-
|
|
Feb 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.62%
|
$670,000
$67.72 P/Share
|
|
Feb 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,334
-0.26%
|
$1,265,046
$69.02 P/Share
|
|
Jan 15
2021
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Indirect |
50,000
-1.27%
|
$3,550,000
$71.51 P/Share
|
|
Jan 04
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
88,334
-0.21%
|
$6,625,050
$75.39 P/Share
|
|
Jan 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
70,000
-0.67%
|
$5,180,000
$74.87 P/Share
|